Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
Arginine depleter
DRUG CLASS:
Arginine depleter
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
pegargiminase (3)
pegargiminase (3)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
ASS1 mutation
Malignant Pleural Mesothelioma
ASS1 mutation
Malignant Pleural Mesothelioma
cisplatin + pemetrexed + pegargiminase
Sensitive: C3 – Early Trials
cisplatin + pemetrexed + pegargiminase
Sensitive
:
C3
cisplatin + pemetrexed + pegargiminase
Sensitive: C3 – Early Trials
cisplatin + pemetrexed + pegargiminase
Sensitive
:
C3
ASS1 negative
Uveal Melanoma
ASS1 negative
Uveal Melanoma
cisplatin + pemetrexed + pegargiminase
Sensitive: C3 – Early Trials
cisplatin + pemetrexed + pegargiminase
Sensitive
:
C3
cisplatin + pemetrexed + pegargiminase
Sensitive: C3 – Early Trials
cisplatin + pemetrexed + pegargiminase
Sensitive
:
C3
ASS1 underexpression
Pancreatic Ductal Adenocarcinoma
ASS1 underexpression
Pancreatic Ductal Adenocarcinoma
panobinostat + pegargiminase
Sensitive: D – Preclinical
panobinostat + pegargiminase
Sensitive
:
D
panobinostat + pegargiminase
Sensitive: D – Preclinical
panobinostat + pegargiminase
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login